Page last updated: 2024-10-22

dan 2163 and Catatonia

dan 2163 has been researched along with Catatonia in 3 studies

Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)

Research Excerpts

ExcerptRelevanceReference
" The authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (NMS) and showed the occurrence of temporal lobe epilepsy (TLE) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities."3.75Catatonia, neuroleptics and brain damage--a case report. ( Chandran, M; El-Shazly, M, 2009)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cevher Binici, N1
Topal, Z1
Demir Samurcu, N1
Cansız, MA1
Savcı, U1
Öztürk, Y1
Özyurt, G1
Tufan, AE1
Chandran, M1
El-Shazly, M1
Saba, G1
Rocamora, JF1
Kalalou, K1
Benadhira, R1
Plaze, M1
Aubriot-Delmas, B1
Januel, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456]60 participants (Anticipated)Interventional2023-11-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for dan 2163 and Catatonia

ArticleYear
Response of Catatonia to Amisulpride and Lorazepam in an Adolescent with Schizophenia.
    Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Amisulpride; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Humans; Lorazepam; Ma

2018
Catatonia, neuroleptics and brain damage--a case report.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2

    Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe

2009
Catatonia and transcranial magnetic stimulation.
    The American journal of psychiatry, 2002, Volume: 159, Issue:10

    Topics: Adolescent; Amisulpride; Antipsychotic Agents; Catatonia; Female; Humans; Prefrontal Cortex; Schizop

2002